Please login to the form below

Dupixent

This page shows the latest Dupixent news and features for those working in and with pharma, biotech and healthcare.

There is plenty of competition in the field, with Pfizer’s Eucrisa and Regeneron and Sanofi’s Dupixent already on the market.

GSK sells eczema and psoriasis drug to Dermavant for £250m

Meanwhile, in atopic dermatitis, Regeneron and Sanofi’s IL4/IL-13 inhibitor Dupixent (dupilumab) was the first biologic to be approved for the condition but seems to have stalled a little,
Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK's Sanofi's Dupixent and more

Daily Brief: Airbus relocation woes, inflated taxes will pay for NHS boost, NICE OK's Sanofi's Dupixent and more. ... Read more from the BBC here: . NICE says yes to Sanofi’s Dupixent. England’s cost effectiveness watchdog NICE has recommended
Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

This year, the judges concluded that just two entrants were worthy of being shortlisted for the Innovative Product Award; Sanofi (Dupixent) and Amicus (Galafold).
Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

UK MARKET ACCESS. NICE decides on Dupixent and Opdivo. England’s cost effectiveness watchdog NICE is to pass judgement on two big products this week – Sanofi’s eczema drug Dupixent and ... The Dupixent decision is due on Wednesday and Opdivo’s
Regeneron’s Dupixent and Praluent fall short

Regeneron’ s Dupixent and Praluent fall short. But CEO Len Schleifer says there’s time to fix that. ... such as asthma, nasal polyps and chronic obstructive pulmonary disease (COPD) “means there is a remarkably broad and deep pipeline within

More from news
Approximately 10 fully matching, plus 13 partially matching documents found.

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Editorial Team Leader, Medical Communications: Excellent package

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home based, Principal Medical Writer, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Add my company

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....